298 related articles for article (PubMed ID: 18347057)
1. Mutation of the PDK1 PH domain inhibits protein kinase B/Akt, leading to small size and insulin resistance.
Bayascas JR; Wullschleger S; Sakamoto K; García-Martínez JM; Clacher C; Komander D; van Aalten DM; Boini KM; Lang F; Lipina C; Logie L; Sutherland C; Chudek JA; van Diepen JA; Voshol PJ; Lucocq JM; Alessi DR
Mol Cell Biol; 2008 May; 28(10):3258-72. PubMed ID: 18347057
[TBL] [Abstract][Full Text] [Related]
2. In vivo role of the phosphate groove of PDK1 defined by knockin mutation.
Collins BJ; Deak M; Murray-Tait V; Storey KG; Alessi DR
J Cell Sci; 2005 Nov; 118(Pt 21):5023-34. PubMed ID: 16219676
[TBL] [Abstract][Full Text] [Related]
3. Characterization of GSK2334470, a novel and highly specific inhibitor of PDK1.
Najafov A; Sommer EM; Axten JM; Deyoung MP; Alessi DR
Biochem J; 2011 Jan; 433(2):357-69. PubMed ID: 21087210
[TBL] [Abstract][Full Text] [Related]
4. Interaction of PDK1 with phosphoinositides is essential for neuronal differentiation but dispensable for neuronal survival.
Zurashvili T; Cordón-Barris L; Ruiz-Babot G; Zhou X; Lizcano JM; Gómez N; Giménez-Llort L; Bayascas JR
Mol Cell Biol; 2013 Mar; 33(5):1027-40. PubMed ID: 23275438
[TBL] [Abstract][Full Text] [Related]
5. Activation of the cardiac mTOR/p70(S6K) pathway by leucine requires PDK1 and correlates with PRAS40 phosphorylation.
Sanchez Canedo C; Demeulder B; Ginion A; Bayascas JR; Balligand JL; Alessi DR; Vanoverschelde JL; Beauloye C; Hue L; Bertrand L
Am J Physiol Endocrinol Metab; 2010 Apr; 298(4):E761-9. PubMed ID: 20051528
[TBL] [Abstract][Full Text] [Related]
6. Activation of serum- and glucocorticoid-regulated protein kinase by agonists that activate phosphatidylinositide 3-kinase is mediated by 3-phosphoinositide-dependent protein kinase-1 (PDK1) and PDK2.
Kobayashi T; Cohen P
Biochem J; 1999 Apr; 339 ( Pt 2)(Pt 2):319-28. PubMed ID: 10191262
[TBL] [Abstract][Full Text] [Related]
7. Functional counterparts of mammalian protein kinases PDK1 and SGK in budding yeast.
Casamayor A; Torrance PD; Kobayashi T; Thorner J; Alessi DR
Curr Biol; 1999 Feb; 9(4):186-97. PubMed ID: 10074427
[TBL] [Abstract][Full Text] [Related]
8. The in vivo role of PtdIns(3,4,5)P3 binding to PDK1 PH domain defined by knockin mutation.
McManus EJ; Collins BJ; Ashby PR; Prescott AR; Murray-Tait V; Armit LJ; Arthur JS; Alessi DR
EMBO J; 2004 May; 23(10):2071-82. PubMed ID: 15116068
[TBL] [Abstract][Full Text] [Related]
9. The role of 3-phosphoinositide-dependent protein kinase 1 in activating AGC kinases defined in embryonic stem cells.
Williams MR; Arthur JS; Balendran A; van der Kaay J; Poli V; Cohen P; Alessi DR
Curr Biol; 2000 Apr; 10(8):439-48. PubMed ID: 10801415
[TBL] [Abstract][Full Text] [Related]
10. In vivo role of the PIF-binding docking site of PDK1 defined by knock-in mutation.
Collins BJ; Deak M; Arthur JS; Armit LJ; Alessi DR
EMBO J; 2003 Aug; 22(16):4202-11. PubMed ID: 12912918
[TBL] [Abstract][Full Text] [Related]
11. 3-Phosphoinositide-dependent protein kinase-1 (PDK1): structural and functional homology with the Drosophila DSTPK61 kinase.
Alessi DR; Deak M; Casamayor A; Caudwell FB; Morrice N; Norman DG; Gaffney P; Reese CB; MacDougall CN; Harbison D; Ashworth A; Bownes M
Curr Biol; 1997 Oct; 7(10):776-89. PubMed ID: 9368760
[TBL] [Abstract][Full Text] [Related]
12. Evidence that 3-phosphoinositide-dependent protein kinase-1 mediates phosphorylation of p70 S6 kinase in vivo at Thr-412 as well as Thr-252.
Balendran A; Currie R; Armstrong CG; Avruch J; Alessi DR
J Biol Chem; 1999 Dec; 274(52):37400-6. PubMed ID: 10601311
[TBL] [Abstract][Full Text] [Related]
13. The PIF-binding pocket in PDK1 is essential for activation of S6K and SGK, but not PKB.
Biondi RM; Kieloch A; Currie RA; Deak M; Alessi DR
EMBO J; 2001 Aug; 20(16):4380-90. PubMed ID: 11500365
[TBL] [Abstract][Full Text] [Related]
14. Dissecting the role of the 3-phosphoinositide-dependent protein kinase-1 (PDK1) signalling pathways.
Bayascas JR
Cell Cycle; 2008 Oct; 7(19):2978-82. PubMed ID: 18802401
[TBL] [Abstract][Full Text] [Related]
15. Serine 396 of PDK1 is required for maximal PKB activation.
Moon Z; Wang Y; Aryan N; Mousseau DD; Scheid MP
Cell Signal; 2008 Nov; 20(11):2038-49. PubMed ID: 18718528
[TBL] [Abstract][Full Text] [Related]
16. WNK1, the kinase mutated in an inherited high-blood-pressure syndrome, is a novel PKB (protein kinase B)/Akt substrate.
Vitari AC; Deak M; Collins BJ; Morrice N; Prescott AR; Phelan A; Humphreys S; Alessi DR
Biochem J; 2004 Feb; 378(Pt 1):257-68. PubMed ID: 14611643
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of phosphorylation of protein kinase B/Akt by a constitutively active 3-phosphoinositide-dependent protein kinase-1.
Wick MJ; Dong LQ; Riojas RA; Ramos FJ; Liu F
J Biol Chem; 2000 Dec; 275(51):40400-6. PubMed ID: 11006271
[TBL] [Abstract][Full Text] [Related]
18. 3-Phosphoinositide-dependent protein kinase 1 (PDK1) phosphorylates and activates the p70 S6 kinase in vivo and in vitro.
Alessi DR; Kozlowski MT; Weng QP; Morrice N; Avruch J
Curr Biol; 1998 Jan; 8(2):69-81. PubMed ID: 9427642
[TBL] [Abstract][Full Text] [Related]
19. Phosphoinositide-dependent phosphorylation of PDK1 regulates nuclear translocation.
Scheid MP; Parsons M; Woodgett JR
Mol Cell Biol; 2005 Mar; 25(6):2347-63. PubMed ID: 15743829
[TBL] [Abstract][Full Text] [Related]
20. PDK1 and PKB/Akt: ideal targets for development of new strategies to structure-based drug design.
Harris TK
IUBMB Life; 2003 Mar; 55(3):117-26. PubMed ID: 12822887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
